tiprankstipranks
Pyxis Oncology (PYXS)
NASDAQ:PYXS
US Market

Pyxis Oncology (PYXS) Technical Analysis

307 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
4Neutral
7Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Pyxis Oncology’s (PYXS) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting Pyxis Oncology is a Sell.
Pyxis Oncology’s (PYXS) 20-Day exponential moving average is 3.26, while Pyxis Oncology’s (PYXS) share price is $3.48, making it a Buy.
Pyxis Oncology’s (PYXS) 50-Day exponential moving average is 3.56, while Pyxis Oncology’s (PYXS) share price is $3.48, making it a Sell.

Pyxis Oncology (PYXS) Pivot Points

Jul 22, 2024, 11:50 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.90
3.03
3.14
3.27
3.38
3.51
3.62
Fibonacci
3.03
3.13
3.18
3.27
3.37
3.42
3.51
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pyxis Oncology (PYXS) Moving Averages

Jul 22, 2024, 11:50 AM
Period
Simple
Exponential
MA5
3.35Buy
3.32Buy
MA10
3.15Buy
3.24Buy
MA20
3.14Buy
3.26Buy
MA50
3.60Sell
3.56Sell
MA100
4.32Sell
3.73Sell
MA200
3.35Buy
3.22Buy
Pyxis Oncology’s (PYXS) 10-Day exponential moving average is 3.24, while Pyxis Oncology’s (PYXS) share price is $3.48, making it a Buy.
Pyxis Oncology’s (PYXS) 100-Day exponential moving average is 3.73, while Pyxis Oncology’s (PYXS) share price is $3.48, making it a Sell.
Pyxis Oncology’s (PYXS) stock price is $3.48 and Pyxis Oncology’s (PYXS) 50-day simple moving average is 3.60, creating a Sell signal.
Pyxis Oncology’s (PYXS) stock price is $3.48 and Pyxis Oncology’s (PYXS) 100-day simple moving average is 4.32, creating a Sell signal.
Pyxis Oncology’s (PYXS) stock price is $3.48 and Pyxis Oncology’s (PYXS) 200-day simple moving average is 3.35, creating a Buy signal.

Pyxis Oncology (PYXS) Technical Indicators

Jul 22, 2024, 11:50 AM
Name
Value
Implied Action
RSI (14)
54.66
Neutral
STOCH (9,6)
62.73
Neutral
STOCHRSI (14)
62.73
Neutral
MACD (12,26)
-0.08
Sell
ADX (14)
19.21
Buy
Williams %R
-19.18
Sell
CCI (14)
108.86
Sell
ATR (14)
0.26
-
Ultimate Oscillator
47.51
Neutral
ROC
5.14
Buy
Pyxis Oncology’s (PYXS) Relative Strength Index (RSI) is 54.66, creating a Neutral signal.
Pyxis Oncology’s (PYXS) Trend Strength Indicator (ADX) is 19.21, creating a Buy signal.
Pyxis Oncology’s (PYXS) Commodity Channel Index (CCI) is 108.86, creating a Sell signal.
Pyxis Oncology’s (PYXS) Price Rate of Change (ROC) is 5.14, creating a Buy signal.

FAQ

Is PYXS a Buy, Hold, or Sell?
Based on PYXS’s technical indicators, PYXS is a Buy.
    What is PYXS’s RSI (14)?
    PYXS’s RSI (14) is 54.66, which suggests PYXS is a Neutral.
      What is PYXS’s MACD?
      PYXS’s MACD is -0.08, which suggests PYXS is a Sell.
        What is PYXS’s 5-day moving average?
        PYXS’s 5-day moving average is 3.35, which suggests PYXS is a Buy.
          What is PYXS’s 20-day moving average?
          PYXS 20-day moving average is 3.14, which suggests PYXS is a Buy.
            What is PYXS’s 50-day moving average?
            PYXS’s 50-day moving average is 3.60, which suggests PYXS is a Sell.
              What is PYXS’s 200-day moving average?
              PYXS’s 200-day moving average is 3.35, which suggests PYXS is a Buy.
                What is PYXS’s Williams % R (14)?
                PYXS’s Williams % R (14) is -19.18, which suggests PYXS is a Sell.
                  What is PYXS’s CCI (14)?
                  PYXS’s CCI (14) is 108.86, which suggests PYXS is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis